News & Updates
Filter by Specialty:
Benralizumab helps maintain severe asthma control with reduced ICS doses
22 Sep 2023
byJairia Dela Cruz
Treatment with benralizumab allows tapering of inhaled corticosteroid (ICS) doses for patients with severe eosinophilic asthma, without compromising disease control and increasing exacerbations, as shown in the results of the phase IV SHAMAL study.
Benralizumab helps maintain severe asthma control with reduced ICS doses
22 Sep 2023Pos Malaysia’s medication delivery service becoming popular
22 Sep 2023
bySaras Ramiya
Pos Malaysia’s Ubat Melalui Pos (UMP) service, launched in 2011, has been offering the delivery of prescription medication to patients located within the PosLaju area of coverage for a minimal fee.